For newly diagnosed ALK or EGFR + NSCLC with oligometastases to brain only and otherwise cN0-1 thoracic disease, would you offer alectinib/osimertinib alone or SRS to brain + concurrent chemoradiation/surgery to chest?

Topics: Thoracic Malignancies • Medical Oncology

Answer from: Medical Oncologist at Community Practice

For asymptomatic patients with smaller lesions, I would offer initial osimerinib or alectinib and get MRI with SRS planning sequences at 1month. We would then SRS any non-responding lesions

Comments

Medical Oncologist at Penn State Health
@Sandip P. Patel, Thank you for your response. I c...

Medical Oncologist at UCSD Moores Cancer Center
I think oligometastatic consolidative sbrt for a p...

Related Questions